These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 16247489

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Association studies of serum prostate-specific antigen levels and the genetic polymorphisms at the androgen receptor and prostate-specific antigen genes.
    Xu J, Meyers DA, Sterling DA, Zheng SL, Catalona WJ, Cramer SD, Bleecker ER, Ohar J.
    Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):664-9. PubMed ID: 12101115
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Genetic polymorphism and carbonic anhydrase 9 expression can predict nodal metastatic prostate cancer risk in patients with prostate-specific antigen levels ≤10 ng/ml at initial biopsy.
    Lin CY, Wang SS, Yang CK, Li JR, Chen CS, Hung SC, Chiu KY, Cheng CL, Ou YC, Yang SF.
    Urol Oncol; 2019 Nov; 37(11):814.e9-814.e16. PubMed ID: 31155437
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Validation of association of genetic variants at 10q with prostate-specific antigen (PSA) levels in men at high risk for prostate cancer.
    Chang BL, Hughes L, Chen DY, Gross L, Ruth K, Giri VN.
    BJU Int; 2014 May; 113(5b):E150-6. PubMed ID: 23937305
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. SPINK1 Promoter Variants Are Associated with Prostate Cancer Predisposing Alterations in Benign Prostatic Hyperplasia Patients.
    Winchester D, Ricks-Santi L, Mason T, Abbas M, Copeland RL, Beyene D, Jingwi EY, Dunston GM, Kanaan YM.
    Anticancer Res; 2015 Jul; 35(7):3811-9. PubMed ID: 26124326
    [Abstract] [Full Text] [Related]

  • 31. Promoter methylation of MCAM, ERα and ERβ in serum of early stage prostate cancer patients.
    Brait M, Banerjee M, Maldonado L, Ooki A, Loyo M, Guida E, Izumchenko E, Mangold L, Humphreys E, Rosenbaum E, Partin A, Sidransky D, Hoque MO.
    Oncotarget; 2017 Feb 28; 8(9):15431-15440. PubMed ID: 28147335
    [Abstract] [Full Text] [Related]

  • 32. Clinical presentation of prostate cancer in black South Africans.
    Tindall EA, Monare LR, Petersen DC, van Zyl S, Hardie RA, Segone AM, Venter PA, Bornman MS, Hayes VM.
    Prostate; 2014 Jun 28; 74(8):880-91. PubMed ID: 24723425
    [Abstract] [Full Text] [Related]

  • 33. PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibility.
    Lai J, Kedda MA, Hinze K, Smith RL, Yaxley J, Spurdle AB, Morris CP, Harris J, Clements JA.
    Carcinogenesis; 2007 May 28; 28(5):1032-9. PubMed ID: 17151093
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Earlier prostate-specific antigen testing in African American men--Clinical support for the recommendation.
    Saltzman AF, Luo S, Scherrer JF, Carson KD, Grubb RL, Hudson MA.
    Urol Oncol; 2015 Jul 28; 33(7):330.e9-17. PubMed ID: 25937424
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men.
    Preston MA, Gerke T, Carlsson SV, Signorello L, Sjoberg DD, Markt SC, Kibel AS, Trinh QD, Steinwandel M, Blot W, Vickers AJ, Lilja H, Mucci LA, Wilson KM.
    Eur Urol; 2019 Mar 28; 75(3):399-407. PubMed ID: 30237027
    [Abstract] [Full Text] [Related]

  • 38. Utility of incorporating genetic variants for the early detection of prostate cancer.
    Nam RK, Zhang WW, Trachtenberg J, Seth A, Klotz LH, Stanimirovic A, Punnen S, Venkateswaran V, Toi A, Loblaw DA, Sugar L, Siminovitch KA, Narod SA.
    Clin Cancer Res; 2009 Mar 01; 15(5):1787-93. PubMed ID: 19223501
    [Abstract] [Full Text] [Related]

  • 39. Association study between common variations in some candidate genes and prostate adenocarcinoma predisposition through multi-stage approach in Iranian population.
    Beikzadeh B, Angaji SA, Abolhasani M.
    BMC Med Genet; 2020 Apr 15; 21(1):81. PubMed ID: 32295536
    [Abstract] [Full Text] [Related]

  • 40. A genetic score can identify men at high risk for prostate cancer among men with prostate-specific antigen of 1-3 ng/ml.
    Nordström T, Aly M, Eklund M, Egevad L, Grönberg H.
    Eur Urol; 2014 Jun 15; 65(6):1184-90. PubMed ID: 23891454
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.